Table of contents
- See VitaminDWiki
- See also web
- Vitamin D Receptor Gene: Ways to Activate it, Calcitriol, Benefits - Nov 2018
- Biological effects of combined resveratrol and vitamin D3 on ovarian tissue - Sept 2017
- Resveratrol potentiated meolxicam to treat knee Osteoartiritis - RCT Sept 2018 (VDR suspected by VitaminDWiki)
- Resveratrol and vitamin D: Significant potential interpretative problems arising from their mutual processes, interactions and effects - 2011
- Resveratrol potentiates vitamin D and nuclear receptor signaling - June 2015
- Resveratrol increases bone density in Diabetics - RCT Sept 2018 (receptor not mentioned)
- The Role of Resveratrol in Cancer Therapy - Dec 2017
- Resveratrol and Cardiovascular Diseases - May 2016
- Anticancer Molecular Mechanisms of Resveratrol - April 2016
- Beneficial action of resveratrol: How and why? - Feb 2016
- Vitamin D and resveratrol prevent Cognitive Decline (in mice) - Feb 2017
- Resveratrol + Vitamin D capsules on Amazon
- Resveratrol + Vitamin D greatly reduce area of muscle damage after heart attack - 2016
- Resveratol helps vitamin D bind to cells – Dec 2014
- Resveratrol improves health (Vitamin D receptor, etc.)
- Decrease of Alzheimer’s biomarker halted by Resveratrol (perhaps due to vitamin D) – RCT Sept 2015
- Resveratrol Linus Pauling Institute
Excellent description of the science
One study using just 8 mg of Resveratrol found benefit
Mentions many receptors, but not Vitamin D Receptor
- Regulation of the human vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites, 2005 DOI: 10.1016/j.mce.2004.11.001
- Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms- Oct 2016 doi: 10.1016/j.semcancer.2015.11.001
- Effects of exercise training and resveratrol on vascular health in aging - Sept 2016 doi: 10.1016/j.freeradbiomed.2016.03.037
- Resveratrol and Omega-3 Fatty Acid: Its Implications in Cardiovascular Diseases - Dec 2015
Download the PDF from VitaminDWiki
- Resveratrol News > 300 items as of Dec 2018. all by Bill Sardi?
Active Vitamin D vs Vitamin D3
The Benefits of Vitamin D3
Natural Ways to Increase Calcitrol and Vitamin D Receptor Gene Expression
What Inhibits The Vitamin D Receptor (VDR) or Calcitriol
Pathogens That Inhibit The Vitamin D Receptor
High Levels of Calcitriol Indicate Inflammatory/Autoimmune Disease
Figuring Out Calcitriol Levels Of Vitamin D3
Irregular Calcitriol Levels?
21 Unique Benefits of Resveratrol + Food Sources, Dosage Self-Hack Updated Dec 2018
What is Resveratrol?
Resveratrol Health Benefits
1) Resveratrol is an Antioxidant
2) Resveratrol is Anti-inflammatory
3) Resveratrol May Be Anti-Aging
4) Resveratrol May Protect the Brain
5) Resveratrol Keeps Your Heart Healthy and Strong
6) Resveratrol Balances the Gut Microbiome and Bile Production
7) Resveratrol May Balance Blood Sugars
8) Resveratrol May Combat Obesity
9) Resveratrol May Boost Bone Health
10) Resveratrol May Prevent Cancer
10) Resveratrol May Improve Liver Health
11) Resveratrol May Enhance Muscle Growth
12) Resveratrol May Protect Against Radiation
13) Resveratrol May Prevent Hearing Loss
14) Resveratrol May Boost Male Sex Hormones
15) Resveratrol May Balance Female Sex Hormones
16) Resveratrol May Reduce Acne
17) Resveratrol May Help Fight Infections
18) Resveratrol Increases Sensitivity to Vitamin D
19) Resveratrol May Reduce Pain
20) Resveratrol May Increase Neurotransmitters in the Brain
21) Resveratrol May Reduce Autoimmunity
Dosage & Supplement Forms
Resveratrol Dietary Sources
Safety & Side Effects
What I Use Resveratrol For (Joe’s experience)
What is Resveratrol?
J Ovarian Res. 2017 Sep 15;10(1):61. doi: 10.1186/s13048-017-0357-9.
Uberti F1, Morsanuto V2, Aprile S3, Ghirlanda S2, Stoppa I2, Cochis A4, Grosa G3, Rimondini L4, Molinari C2.
Resveratrol (3,5,4'-trihydroxy-trans-stilbene) is a natural antioxidant polyphenol able to exert a wide range of biological effect on several tissues. Despite its important beneficial properties, it has a low water solubility, which limits its therapeutic applications in humans. Resveratrol also acts as a phytoestrogen that modulates estrogen receptor (ER)-mediated transcription. In addition, it has been shown that ovarian tissues benefit greatly from vitamin D3, which exerts its beneficial effects through VDR receptors. The aim was to evaluate the cooperative effects of resveratrol combined with vitamin D3 on ovarian cells and tissues and some other organs as well. Moreover, the modulation of specific intracellular pathways involving ER and VDR receptors has been studied.
METHODS: The experiments were performed both in vitro and in vivo, to analyze cell viability, radical oxygen species production, signal transductions through Western Blot, and resveratrol quantification by HPLC.
Cell viability, radical oxygen species production, and intracellular pathways have been studied on CHO-K1 cells. Also, the relative mechanism activated following oral intake in female Wistar rats as animal model was investigated, evaluating bioavailability, biodistribution and signal transduction in heart, kidney, liver and ovarian tissues. Both in in vitro and in vivo experiments, resveratrol exerts more evident effects when administered in combination with vitD in ovarian cells, showing a common biphasic cooperative effect: The role of vitamin D3 in maintaining and supporting the biological activity of resveratrol has been clearly observed. Moreover, resveratrol plus vitamin D3 blood concentrations showed a biphasic absorption rate.
CONCLUSIONS: Such results could be used as a fundamental data for the development of new therapies for gynecological conditions, such as hot-flashes.
Resveratrol potentiated meolxicam to treat knee Osteoartiritis - RCT Sept 2018 (VDR suspected by VitaminDWiki)
Efficacy and safety of co-administration of resveratrol with meloxicam in patients with knee osteoarthritis: a pilot interventional study.
Clin Interv Aging. 2018 Sep 5;13:1621-1630. doi: 10.2147/CIA.S172758. eCollection 2018.
Hussain SA1, Marouf BH2, Ali ZS3, Ahmmad RS1.
500 mg for 3 months helped a lot. Vitamin D levels in blood were not raised, but VitaminDWiki suspects vitamin D levels in tissues were raised
BACKGROUND AND AIM: Resveratrol shows remarkable anti-inflammatory activities in experimental models. This study aims to evaluate the effect of resveratrol, as an adjuvant with meloxicam (Mlx), on the pain and functional activity during a 90-day period and monitor the adverse effects on kidney and liver functions, lipid profile, and hematological markers.
PATIENTS AND METHODS:
This study was a double-blind, placebo-controlled, randomized multi-center study that involved 110 patients with knee osteoarthritis (OA) and was performed at Sulaimani City, Iraq, from December 2016 to September 2017. To assess the effects of Mlx with or without resveratrol, pain severity and functional disability were evaluated at baseline and after 90 days using the Western Ontario and McMaster Universities Osteoarthritis Index. Fasting blood was collected to evaluate the lipid profile markers, hematological picture, and liver and kidney functions, in addition to vitamin D level.
RESULTS: Resveratrol significantly improves pain, functions, and associated symptoms compared with placebo. The clinical and biochemical markers indicated that 500 mg/day of resveratrol, as an adjuvant with Mlx, is safe and well tolerated by the knee OA patients.
CONCLUSION: Resveratrol, as an "add-on" medication with Mlx, was superior in terms of safety and efficacy to Mlx alone for the treatment of pain and improvement of physical function in patients with knee OA.
Resveratrol and vitamin D: Significant potential interpretative problems arising from their mutual processes, interactions and effects - 2011
Daniel P Hayes
Med Hypotheses () (2011) PMID 21840648
The hypothesis is formulated and presented that resveratrol and vitamin D have important mutual processes, interactions and induced effects that if not taken into account could seriously jeopardize the interpretation of their current and future preclinical, epidemiological and clinical studies.
In support of this hypothesis, evidence is presented that resveratrol and vitamin D mutually share some of the same biochemical processes and mechanisms as well as the fact that they can each affect some of the same diseases and maladies. Copyright © 2011 Elsevier Ltd. All rights reserved.
J Cell Biochem. 2015 Jun;116(6):1130-43. doi: 10.1002/jcb.25070.
Dampf Stone A1, Batie SF, Sabir MS, Jacobs ET, Lee JH, Whitfield GK, Haussler MR, Jurutka PW.
1School of Mathematical and Natural Sciences, Arizona State University, Glendale, Arizona, 85306.
The 1,25-dihydroxyvitamin D3 (1,25D) hormone is derived from vitamin D generated in skin or obtained from the diet, and binds to and activates the vitamin D receptor (VDR) in target tissues including kidney, colon/small intestine, and bone/muscle. We tested resveratrol for its ability to modulate VDR signaling, using vitamin D responsive element (VDRE) and mammalian 2-hybrid (M2H) transcriptional system technology. Via VDRE-based assays in kidney, colon and myoblast cells, VDR-mediated transcription was activated by resveratrol, and a cooperative effect on transactivation was observed with resveratrol plus 1,25D. The M2H assay revealed a modest, resveratrol-induced dimerization of VDR with its retinoid X receptor (RXR) heteropartner. Cells treated with both resveratrol and 1,25D displayed synergistic stimulation of VDR-RXR heterodimerization, while resveratrol antagonized rexinoid-mediated RXR-RXR homodimerization. Increased transactivation in response to resveratrol was also observed with a subset of other nuclear receptors and their respective cognate responsive elements. Evaluation of wild-type versus a ligand-binding domain mutant VDR revealed that hormone-responsiveness to 1,25D was severely depressed, while the response to resveratrol was only moderately attenuated. Moreover, radiolabeled 1,25D-displacement assays demonstrated an increase in VDR-bound 1,25D in the presence of resveratrol. Thus, resveratrol may affect VDR and other nuclear receptors indirectly, likely via the ability of resveratrol to: (1) potentiate 1,25D binding to VDR; (2) activate RXR; and/or (3) stimulate SIRT1, an enzyme known to deacetylate nuclear receptors. The results of this study elucidate a possible pathway for crosstalk between two nutritionally derived lipids, vitamin D and resveratrol, both of which converge on VDR signaling.
Notes after quick read - 4X increase in Vitamin D response by cells when resveratrol was added to a poorly functioning VDR
Many charts show response of the order of 4X, but unsure of the vertical axis
Effects of resveratrol on bone health in type 2 diabetic patients. A double-blind randomized-controlled trial
Nutr Diabetes. 2018 Sep 20;8(1):51. doi: 10.1038/s41387-018-0059-4.
Bo S1, Gambino R2, Ponzo V2, Cioffi I3, Goitre I2, Evangelista A4, Ciccone G4, Cassader M2, Procopio M2.
OBJECTIVES: Patients with type 2 diabetes (T2DM) are at increased fracture risk. Resveratrol has shown beneficial effects on bone health in few studies. The aim of this trial was to investigate the effects of resveratrol on bone mineral density (BMD) and on calcium metabolism biomarkers in T2DM patients.
METHODS: In this double-blind randomized placebo-controlled trial 192 T2DM outpatients were randomized to receive resveratrol 500 mg/day (Resv500 arm), resveratrol 40 mg/day (Resv40 arm) or placebo for 6 months. BMD, bone mineral content (BMC), serum calcium, phosphorus, alkaline phosphatase, and 25-hydroxy vitamin D were measured at baseline and after 6 months.
RESULTS: At follow-up, calcium concentrations increased in all patients, while within-group variations in alkaline phosphatase were higher in both resveratrol arms, and 25-hydroxy vitamin D increased in the Resv500 arm only, without between-group differences. Whole-body BMD significantly decreased in the placebo group, while whole-body BMC decreased in both the placebo and Resv40 arms. No significant changes in BMD and BMC values occurred in the Resv500 arm. The adjusted mean differences of change from baseline were significantly different in the Resv500 arm vs placebo for whole-body BMD (0.01 vs -0.03 g/cm2, p = 0.001), whole-body BMC (4.04 vs -58.8 g, p < 0.001), whole-body T-score (0.15 vs -0.26), and serum phosphorus (0.07 vs -0.01 µmol/L, p = 0.002). In subgroup analyses, in Resv500 treated-patients BMD values increased to higher levels in those with lower calcium and 25-hydroxy vitamin D values, and in alcohol drinkers.
CONCLUSIONS: Supplementation with 500 mg resveratrol prevented bone density loss in patients with T2DM, in particular, in those with unfavorable conditions at baseline.
Nutrients. 2016 May 2;8(5). pii: E250. doi: 10.3390/nu8050250.
The increased incidence of cardiovascular diseases (CVDs) has stimulated research for substances that could improve cardiovascular health. Among them, resveratrol (RES), a polyphenolic compound notably present in grapes and red wine, has been involved in the "French paradox". RES is known for its antioxidant and anti-inflammatory properties and for its ability to upregulate endothelial NO synthase (eNOS). RES was able to scavenge (•)OH/O₂(•-) and peroxyl radicals, which can limit the lipid peroxidation processes. Moreover, in bovine aortic endothelial cells (BAEC) under glucose-induced oxidative stress, RES restored the activity of dimethylargininedimethylaminohydrolase (DDAH), an enzyme that degrades an endogenous inhibitor of eNOS named asymmetric dimethylarginine (ADMA). Thus, RES could improve (•)NO availability and decrease the endothelial dysfunction observed in diabetes. Preclinical studies have made it possible to identify molecular targets (SIRT-1, AMPK, Nrf2, NFκB…); however, there are limited human clinical trials, and difficulties in the interpretation of results arise from the use of high-dose RES supplements in research studies, whereas low RES concentrations are present in red wine. The discussions on potential beneficial effects of RES in CVDs (atherosclerosis, hypertension, stroke, myocardial infarction, heart failure) should compare the results of preclinical studies with those of clinical trials.
Front Nutr. 2016 Apr 12;3:8. doi: 10.3389/fnut.2016.00008. eCollection 2016.
Varoni EM1, Lo Faro AF1, Sharifi-Rad J2, Iriti M3.
Resveratrol is a pleiotropic phytochemical belonging to the stilbene family. Though it is only significantly present in grape products, a huge amount of preclinical studies investigated its anticancer properties in a plethora of cellular and animal models. Molecular mechanisms of resveratrol involved signaling pathways related to extracellular growth factors and receptor tyrosine kinases; formation of multiprotein complexes and cell metabolism; cell proliferation and genome instability; cytoplasmic tyrosine kinase signaling (cytokine, integrin, and developmental pathways); signal transduction by the transforming growth factor-β super-family; apoptosis and inflammation; and immune surveillance and hormone signaling. Resveratrol also showed a promising role to counteract multidrug resistance: in adjuvant therapy, associated with 5-fluoruracyl and cisplatin, resveratrol had additive and/or synergistic effects increasing the chemosensitization of cancer cells. Resveratrol, by acting on diverse mechanisms simultaneously, has been emphasized as a promising, multi-target, anticancer agent, relevant in both cancer prevention and treatment.
Nutrition. 2016 Feb;32(2):174-8. doi: 10.1016/j.nut.2015.08.017. Epub 2015 Sep 25.
Diaz-Gerevini GT1, Repossi G2, Dain A1, Tarres MC3, Das UN4, Eynard AR5.
Flavonoid resveratrol modulates the transcription factor NF-κB; inhibits the cytochrome P450 isoenzyme CYP1 A1; suppresses the expression and activity of cyclooxygenase enzymes; and modulates Fas/Fas-ligand-mediated apoptosis, p53, mammalian target of rapamycin, and cyclins and various phosphodiesterases. This increases the cytosolic cAMP that activates Epac1/CaMKKβ/AMPK/SIRT1/PGC-1α pathway, which in turn facilitates increased oxidation of fatty acids, mitochondrial biogenesis, mitochondrial respiration, and gluconeogenesis. Resveratrol triggers apoptosis of activated T cells and suppresses tumor necrosis factor-α, interluekin-17 (IL-17), and other proinflammatory molecules, and thus is of benefit in autoimmune diseases. In addition, resveratrol inhibits expression of hypoxia-inducible factor-1α and vascular endothelial growth factor, explaining its effective action against cancer. Brain-derived neurotrophic factor (BDNF) that is involved in the pathogenesis of obesity, type 2 diabetes mellitus, and metabolic syndrome is also altered in depression, schizophrenia, bipolar disorder, and autism. We noted that BDNF protects against cytotoxic actions of alloxan, streptozotocin, and benzo(a)pyrene. Resveratrol prevents bisphenol A-induced autism, type 2 diabetes mellitus, and metabolic syndrome, suggesting that it may augment BDNF synthesis and action. We also observed that BDNF levels are low in type 2 diabetes mellitus and that BDNF enhances production of antiinflammatory lipid, lipoxin A4, whose levels are low in diabetes mellitus. Thus, resveratrol may augment production of lipoxin A4. Resveratrol alters gut microbiota and influences stem cell proliferation and differentiation. These pleiotropic actions of resveratrol may explain the multitude of its actions and benefits.
Vitamin D Combined with Resveratrol Prevents Cognitive Decline in SAMP8 Mice
Download the PDF from VitaminDWiki
P8 (evolved to have poor cognition) did much worse than regular mice
Adding just Vitamin D helped
Adding just Reseratrol helped
Great synergy when add both: perhaps even better than regular mouse